Table 4 The parameters of DM groups at the baseline and at end of insulin pump therapy
From: The impact of insulin pump therapy to oxidative stress in patients with diabetic nephropathy
Treatment | T value | P value | ||
|---|---|---|---|---|
Pre- | Pro- | |||
SBP (mmHg) | 132.3 ± 12.1 | 130.5 ± 11.5 | − 4.413 | 0.336 |
DBP (mmHg) | 77.4 ± 5.4 | 75.5 ± 5.8 | − 4.905 | 0.033* |
HBA1c (%) | 10.6 ± 1.5 | 10.5 ± 1.5 | − 1.85 | 0.068 |
FPG (mmol/l) | 12.4 ± 1.8 | 7.3 ± 1.0 | − 23.006 | 0.000* |
2hPG (mmol/l) | 16.5 ± 1.2 | 9.1 ± 1.1 | − 40.791 | 0.000* |
IR | 3.3 ± 0.5 | 2.6 ± 0.4 | − 16.508 | 0.000* |
TC (mmol/l) | 5.0 ± 1.0 | 3.4 ± 0.9 | − 15.075 | 0.000* |
TG (mmol/l) | 2.8 ± 0.9 | 2.4 ± 0.9 | − 4.22 | 0.000* |
CRP (mg/l) | 8.46 ± 1.79 | 6.00 ± 1.60 | − 13.14 | 0.000* |
IL-6 (pg/l) | 167.90 ± 15.46 | 106.95 ± 17.80 | − 43.08 | 0.000* |
3-NT (nmol/l) | 121.5 ± 9.9 | 114.6 ± 9.5 | − 12.064 | 0.000* |
SOD (U/ml) | 102.6 ± 20.5 | 115.0 ± 18.3 | 19.31 | 0.000* |
8-OHdG (ng/ml) | 25.4 ± 4.4 | 21.3 ± 4.9 | − 12.109 | 0.000* |
GSH (mg/l) | 134.3 ± 15.3 | 145.0 ± 14.0 | 14.946 | 0.000* |
LDL (mmol/l) | 3.3 ± 0.8 | 2.5 ± 0.6 | − 7.943 | 0.000* |
HDL (mmol/l) | 1.1 ± 0.4 | 1.3 ± 0.4 | 4.881 | 0.000* |